Bourjeily-Habr G, Rochester C L, Palermo F, Snyder P, Mohsenin V
Section of Pulmonary and Critical Care Medicine, Yale University, New Haven, CT 06520, USA.
Thorax. 2002 Dec;57(12):1045-9. doi: 10.1136/thorax.57.12.1045.
Although exercise training improves exercise tolerance in most patients with chronic obstructive pulmonary disease (COPD), some patients with severe disease may not be able to tolerate exercise training due to incapacitating breathlessness. Transcutaneous electrical muscle stimulation (TCEMS) has been shown to improve muscle strength, muscle mass, and performance in paraplegics, patients with knee ligament injury, and patients with peripheral vascular disease. We hypothesised that TCEMS of the lower extremities can improve muscle strength and exercise tolerance in patients with moderate to severe COPD.
A randomised controlled trial of TCEMS of the lower extremities was performed in 18 medically stable patients of mean (SD) age 60.0 (1.5) years with a mean forced expiratory volume in 1 second (FEV(1)) of 1.03 (0.10) l (38% predicted) and residual volume/total lung capacity (RV/TLC) of 59 (2)%. Stimulation of the lower extremities was performed three times a week, 20 minutes each session, for six continuous weeks. Quadriceps and hamstring muscle strength, exercise capacity, and peak oxygen uptake were measured at baseline and after 6 weeks of stimulation.
TCEMS improved both the quadriceps strength (by 39.0 (20.4)% v 9.0 (8.1)%, p=0.046) and hamstring muscle strength (by 33.9 (13.0)% v 2.9 (4.7)%, p=0.038) in the treated (n=9) and sham treated (n=9) groups, respectively. The improvement in muscle strength carried over to better performance in the shuttle walk test in the treated group (36.1% v 1.6% in the treated and sham groups respectively, p=0.007, Mann-Whitney U test). There was no significant change in lung function, peak workload, or peak oxygen consumption in either group. Muscle stimulation was well tolerated by the patients with no dropouts and better than 95% compliance with the protocol.
TCEMS of peripheral muscles can be a useful adjunct to the comprehensive pulmonary rehabilitation of patients with COPD.
尽管运动训练可提高大多数慢性阻塞性肺疾病(COPD)患者的运动耐量,但一些重症患者可能因严重呼吸困难而无法耐受运动训练。经皮电肌肉刺激(TCEMS)已被证明可改善截瘫患者、膝关节韧带损伤患者和外周血管疾病患者的肌肉力量、肌肉质量及运动能力。我们推测,下肢TCEMS可改善中度至重度COPD患者的肌肉力量和运动耐量。
对18例病情稳定的患者进行了一项关于下肢TCEMS的随机对照试验,这些患者的平均(标准差)年龄为60.0(1.5)岁,平均1秒用力呼气量(FEV₁)为1.03(0.10)升(预计值的38%),残气量/肺总量(RV/TLC)为59(2)%。下肢刺激每周进行3次,每次20分钟,持续6周。在基线及刺激6周后测量股四头肌和腘绳肌力量、运动能力及峰值摄氧量。
在治疗组(n = 9)和假治疗组(n = 9)中,TCEMS分别改善了股四头肌力量(分别为39.0(20.4)%对9.0(8.1)%,p = 0.046)和腘绳肌力量(分别为33.9(13.0)%对2.9(4.7)%,p = 0.038)。治疗组肌肉力量的改善转化为往返步行试验中更好的表现(治疗组和假治疗组分别为36.1%对1.6%,p = 0.007,曼-惠特尼U检验)。两组的肺功能、峰值工作量或峰值耗氧量均无显著变化。患者对肌肉刺激耐受性良好,无脱落病例,且依从方案的比例超过95%。
外周肌肉的TCEMS可作为COPD患者综合肺康复的有益辅助手段。